Results 291 to 300 of about 936,037 (347)

CT in hepatic cirrhosis and chronic hepatitis

Seminars in Ultrasound, CT and MRI, 2002
Cirrhosis is a diffuse liver disease with premalignant potential in which hepatocellular carcinoma (HCC) frequently develops. The hemodynamics of contrast material are the key to diagnosis of focal liver lesions with computed tomography (CT). Lesions with arterial-dominant vascularity, such as HCC, show brisk enhancement during the arterial phase ...
Carlos, Valls, Eduard, Andía, Yolanda, Roca, Mònica, Cos, Juan, Figueras   +4 more
openaire   +2 more sources

Doppler in hepatic cirrhosis and chronic hepatitis

Seminars in Ultrasound, CT and MRI, 2002
Doppler ultrasound and color Doppler are being used routinely in the study of vascular structures of the abdomen, and more particularly the liver. Reports published in the literature to date have shown that all patients with hepatic cirrhosis and chronic hepatitis should be studied in the first stage of their illness and in follow-up by using Doppler ...
Antonio, Martínez-Noguera, Enric, Montserrat, Sofía, Torrubia, Jordi, Villalba   +3 more
openaire   +2 more sources

Cirrhosis and the Hepatic Photoscan

Radiology, 1969
HEPATIC photoscanning has been utilized mainly for the detection of space-occupying lesions, but cirrhosis may produce localized scan defects indistinguishable from space-occupying lesions (1–4). Colloidal gold (198Au) has been utilized as the hepatic scanning agent and 2 reports have stated that increased splenic uptake of this material should alert ...
openaire   +2 more sources

Chronic Hepatitis and Cirrhosis

Hepatology, 1984
Chronic hepatitis is defined as diffuse chronic liver disease existing for at least 6 months. Cirrhosis is a sequel. It is of multiple etiology. Liver biopsy is essential for diagnosis and prognosis. Hepatitis B-related chronic hepatitis is slowly progressive. Corticosteroid therapy is disappointing.
openaire   +2 more sources

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

The Lancet, 2019
BACKGROUND Clinical decompensation of cirrhosis is associated with poor prognosis. Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure gradient (HVPG) ≥10 mm Hg, is the strongest predictor of decompensation. This study
C. Villanueva, A. Albillos, J. Genescà, J. García-Pagán, J. Calleja, C. Aracil, R. Bañares, R. Morillas, M. Poca, Beatriz Peñas, S. Augustin, J. Abraldes, E. Alvarado, F. Torres, J. Bosch   +14 more
semanticscholar   +1 more source

Hepatic cirrhosis and hepatic ultrastructure in pregnancy.

Biological research in pregnancy and perinatology, 1983
Hepatic cirrhosis rarely occurs with pregnancy. Since no report has been made on hepatic cirrhosis and hepatic ultrastructure in pregnancy, we present a case of cirrhosis and pregnancy in which a study of hepatic ultrastructure was carried out.
ERTUNGEALP, E, KAYALI, H, YILMAZ, S, ATASU, T   +3 more
openaire   +3 more sources

Infective Hepatitis with Hepatic Cirrhosis

Journal of the Royal Army Medical Corps, 1953
A K, THOMAS, J, MACKAY-DICK
openaire   +2 more sources

Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis: A Meta-Analysis

The American surgeon, 2017
Yun-bing Wang, Jian-Ying Zhang, Fan Zhang, Yong Zhao, J. Gong   +4 more
semanticscholar   +1 more source

Hepatic inflammatory responses in liver fibrosis

Nature reviews: Gastroenterology & hepatology, 2023
L. Hammerich, F. Tacke
semanticscholar   +1 more source

Hepatitis and Cirrhosis

Journal of the American Pharmaceutical Association (1961), 1973
openaire   +2 more sources